Get the Stockscreener App
1.7193
4.13%
-0.0707
Alector Inc stock is traded at $1.7193, with a volume of 329.40K.
It is down -4.13% in the last 24 hours and down -13.33% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$1.79
Open:
$1.79
24h Volume:
329.40K
Relative Volume:
0.27
Market Cap:
$175.30M
Revenue:
$97.06M
Net Income/Loss:
$-130.39M
P/E Ratio:
-1.1092
EPS:
-1.55
Net Cash Flow:
$-186.54M
1W Performance:
+3.38%
1M Performance:
-13.33%
6M Performance:
-65.05%
1Y Performance:
-73.19%
1-Day Range:
$1.69
$1.825
1-Week Range:
$1.5901
$1.8549
52-Week Range:
$1.5901
$7.5773
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.72 | 175.30M | 97.06M | -130.39M | -186.54M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.09 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
716.63 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
652.19 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.24 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.75 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
ALEC Stock Sees Surge of Approximately 12.20% in Last Five Days - Knox Daily
Alector, Inc. (NASDAQ:ALEC) Short Interest Update - MarketBeat
Alector stock hits 52-week low at $1.59 amid market challenges - MSN
AbbVie terminates Alector collaboration agreement - MSN
Cantor Fitzgerald Comments on Alector FY2025 Earnings - Defense World
Discovering 3 US Penny Stocks With Market Caps Below $200M - Simply Wall St
Brokerages Set Alector, Inc. (NASDAQ:ALEC) Price Target at $3.75 - Defense World
Barclays PLC Buys 100,731 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Them too in TREM2: Street keeping AD Vigil - BioWorld Online
Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Average Price Target from Brokerages - MarketBeat
Alector stock hits 52-week low at $1.68 amid market challenges - Investing.com Canada
Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025 - GlobeNewswire
Alector Advances Brain Disease Pipeline: Key Trial Results Expected in 2025, $457M Cash Runway - StockTitan
Alector, Inc. Announces Termination of Al002 in Collaboration with Abbvie Biotechnology, Ltd - Marketscreener.com
Alector, Inc. (NASDAQ:ALEC) Stake Raised by JPMorgan Chase & Co. - Defense World
Alector, Inc. (NASDAQ:ALEC) Shares Acquired by JPMorgan Chase & Co. - MarketBeat
Jane Street Group LLC Buys 30,180 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Geode Capital Management LLC Grows Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Reviewing BioNTech (NASDAQ:BNTX) & Alector (NASDAQ:ALEC) - Defense World
Alector stock hits 52-week low at $1.73 amid market challenges - Investing.com
State Street Corp Has $12.19 Million Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Stifel Financial Corp Sells 34,715 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector (ALEC) Stock Dips Amid Mixed Analyst Ratings - GuruFocus.com
The Market Doesn't Like What It Sees From Alector, Inc.'s (NASDAQ:ALEC) Revenues Yet As Shares Tumble 53% - Simply Wall St
Critical Contrast: Relay Therapeutics (NASDAQ:RLAY) & Alector (NASDAQ:ALEC) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 10,920 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector (NASDAQ:ALEC) Rating Lowered to “Neutral” at Mizuho - Defense World
BNP Paribas Financial Markets Cuts Stock Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector (NASDAQ:ALEC) Stock Rating Lowered by Mizuho - MarketBeat
Alector stock under pressure as key AL002 program removed—Mizuho - Investing.com India
Alector (NASDAQ:ALEC) Downgraded to “Hold” Rating by Stifel Nicolaus - Defense World
Alector stock under pressure as key AL002 program removed—Mizuho By Investing.com - Investing.com UK
Alector Inc. stock downgraded to Hold by Stifel, amid mixed biotechnology outlook - Investing.com Australia
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alector Inc Stock (ALEC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rosenthal Arnon | Chief Executive Officer |
Dec 02 '24 |
Sale |
2.52 |
52,172 |
131,442 |
2,507,074 |
| Kenkare-Mitra Sara | President and Head of R&D |
Dec 02 '24 |
Sale |
2.52 |
26,500 |
66,764 |
565,215 |
| Romano Gary | Chief Medical Officer |
Dec 02 '24 |
Sale |
2.52 |
14,892 |
37,519 |
349,283 |
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):